The COVID-19 pandemic has taken millions of lives around the world, making it difficult to say goodbye and accompany our loved ones in their last days and giving rise to multiple situations that are difficult to process emotionally.
True to its social commitment, the Beckley Med Foundation is making available a study to evaluate the potential of ayahuasca assisted by constructivist psychotherapy in the prevention of prolonged bereavement.
The enrolment period for participants will be open from 2021 to 2024, with the aim of serving 216 people who have lost a first-degree relative in the last 12 months.
This study is led by Dr. Debora Gonzalez and has been approved by the HU-GTiP ethics committee (IRB Ref.: PI-19-188).
Men and women between 18 and 65 years of age
Who have lost a first-degree relative
A maximum of 12 months have passed since the death of their relative.
Pregnant or breastfeeding women
Psychotic disorder or history of psychotic disorder
Bipolar disorder or history of such disorder
Psychotropic substance and alcohol abuse
Receiving regular pharmacological or psychological therapy for the treatment of prolonged bereavement during the study.
Think Tank founded in Great Britain in 1998 by Amanda Feilding, a pioneer in psychedelic research in the field of mental health and on Drug Policy reform.
The world’s leading psychedelic research organisation. Rick Doblin’s MAPS is a global leader in training programmes for psychedelic therapists.
The figure of Stan Grof in the history of psychedelics has reached legendary status. His legacy takes the form of a comprehensive psychedelic psychotherapy training programme.